Chem. J. Chinese Universities ›› 2016, Vol. 37 ›› Issue (7): 1229.doi: 10.7503/cjcu20160288

• Letter • Previous Articles     Next Articles

New Tanshinone IIA Delivery System Using Chitosan Nanomicelles of Small Size

LI Hong1,3, DU Libo1, ZHANG Han1, ZHAO Yuming2,*(), LIU Yang1,3,*()   

  1. 1. Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China
    2. School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
    3. University of Chinese Academy of Science, Beijing 100049, China
  • Received:2016-04-24 Accepted:2016-06-06 Online:2016-07-10 Published:2016-06-16
  • Contact: ZHAO Yuming,LIU Yang E-mail:yumingzhao@ccmu.edu.cn;yliu@iccas.ac.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.31570856, 31571020), the Beijing Natural Science Foundation of China(No.5152005) and the 2016 Scientific Research Project of Beijing Educational Committee of China(No.KM201610025003)

Abstract:

It is still a great challenge to design and synthesize ultra-small chitosan nanoparticles for encapsulating highly hydrophobic neuroprotectants, such as anti-stroke drug tanshinone IIA. To address the issue, a new amphiphilic polymeric micelle system(i.e. CS-g-TPS) was synthesized by covalent linking of D-α-tocopherol succinic acid ester with hydroxylethyl-chitosan in a green and effective approach. The results showed that the obtained CS-g-TPS can be self-assembled into ultra-small nanoparticles by hydrophilic-hydrophobic interaction in aqueous solution, which can be effectively loaded with tanshinone IIA. The particle size and morphology were characterized by scanning electron microscopy(SEM) and dynamic light scattering(DLS), respectively. Bioassays of cell viability and drug uptake further revealed that the CS-g-TPS/tanshinone IIA delivery system could achieve excellent in vitro biocompatibility, as well as high cellular uptake efficiency. It indicated that CS-g-TPS might be a promising drug delivery system for water insoluble neuroprotectant with the characteristics of high biosafety.

Key words: Chitosan nanomicelles of small size, Tanshinone IIA, Neuroprotectant, Delivery for poorly soluble drugs

CLC Number: 

TrendMD: